Xovoltib 30mg (Afatinib Dimaleate)

Xovoltib 30 mg (Afatinib)

Xovoltib 30 mg contains afatinib, a targeted anticancer medicine belonging to the tyrosine kinase inhibitor class. Afatinib is used for specific types of metastatic non-small cell lung cancer (NSCLC), particularly tumors with certain non-resistant EGFR mutations. It is also used for metastatic squamous NSCLC that has progressed after platinum-based chemotherapy.

Xovoltib 30 mg is a prescription oncology medicine. The 30 mg strength is not a universal starting dose. Your oncologist determines the appropriate strength based on your cancer, treatment plan, kidney function, side effects, and other clinical factors.

What Is Xovoltib 30 mg?

Xovoltib 30 mg contains afatinib dimaleate as its active pharmaceutical ingredient. Afatinib blocks signals from the epidermal growth factor receptor (EGFR) family and can help slow the growth and spread of certain cancer cells.

The product shown contains 30 mg tablets and is packaged as film-coated tablets. The exact packaging, manufacturer, and pack size can vary by market.

What Is Xovoltib 30 mg Used For?

Afatinib is used in specific patients with advanced or metastatic NSCLC. Treatment selection depends on the tumor’s molecular characteristics and previous therapy.

• Metastatic NSCLC with certain non-resistant EGFR mutations, including exon 19 deletions or exon 21 L858R mutations detected by an appropriate FDA-approved test.
• Metastatic squamous NSCLC that has progressed after platinum-based chemotherapy.

Not every person with lung cancer is a suitable candidate for afatinib. Your oncology team should confirm the diagnosis, cancer subtype, mutation status, and treatment history before therapy begins.

How Does Afatinib Work?

Afatinib is a targeted therapy that inhibits signaling through members of the ErbB receptor family, including EGFR. These signaling pathways can contribute to the growth and survival of certain cancer cells.

By blocking these signals, afatinib may reduce signaling that supports tumor-cell growth. The expected benefit depends on the biological characteristics of the cancer.

Xovoltib 30 mg Dosage

The tablet strength does not determine the correct dose for every patient. The U.S. prescribing information for afatinib lists 40 mg once daily as the recommended dose for the indicated uses. A lower strength, such as 30 mg, may be used in certain circumstances, including dose modification or severe renal impairment.

Therefore, do not start, stop, increase, or reduce Xovoltib 30 mg without instructions from your oncologist. Your healthcare professional may adjust treatment when adverse reactions or other clinical factors occur.

How to Take Xovoltib

• Take afatinib exactly as prescribed by your healthcare professional.
• Take the tablet at least 1 hour before or 2 hours after a meal.
• Swallow the tablet whole with water unless your healthcare professional gives you different instructions.
• Take the medicine at approximately the same time each day.
• Do not change the prescribed strength because of symptoms or side effects without medical advice.

Xovoltib 30 mg Side Effects

Afatinib can cause side effects. Some are manageable with supportive treatment or dose adjustment, while others require urgent medical attention.

Common Side Effects

• Diarrhea
• Rash or acne-like skin inflammation
• Dry skin
• Mouth inflammation or stomatitis
• Nail inflammation or paronychia
• Reduced appetite
• Nausea
• Vomiting
• Itching

Tell your oncology team about persistent or troublesome symptoms. Early management can help reduce complications and may allow treatment to continue safely when appropriate.

Serious Afatinib Side Effects

Some reactions require prompt medical evaluation. Contact your healthcare professional immediately if you develop severe or rapidly worsening symptoms.

• Severe or persistent diarrhea, especially with signs of dehydration
• Severe blistering, peeling, or exfoliation of the skin
• New or worsening cough, breathing difficulty, or other symptoms suggesting lung inflammation
• Yellowing of the skin or eyes or other signs of liver problems
• Severe abdominal pain that could indicate gastrointestinal complications
• New eye pain, redness, light sensitivity, or vision changes
• Severe allergic or hypersensitivity reactions

The FDA identifies diarrhea, serious skin reactions, interstitial lung disease, liver toxicity, gastrointestinal perforation, keratitis, and embryo-fetal toxicity among important warnings and precautions associated with afatinib.

Precautions Before Taking Xovoltib

Before starting treatment, tell your doctor about your complete medical history and all medicines you use.

• Tell your doctor if you have kidney or liver problems.
• Report previous serious skin reactions or lung disease.
• Tell your doctor about gastrointestinal disorders or previous ulcers.
• Discuss any eye problems before treatment.
• Provide a complete list of prescription medicines, nonprescription medicines, vitamins, and supplements.
• Tell your healthcare professional if you are pregnant, planning pregnancy, or may become pregnant.

Afatinib and Pregnancy

Afatinib may cause fetal harm. People who may become pregnant should discuss effective contraception with their healthcare professional during treatment and for the period recommended after treatment.

If pregnancy occurs during treatment, contact your oncology team promptly for medical guidance.

Afatinib and Breastfeeding

Breastfeeding may not be recommended during afatinib treatment because of the potential for serious adverse effects in a breastfed infant. Discuss feeding options with your doctor before starting therapy.

Drug Interactions

Afatinib can interact with other medicines. Your doctor or pharmacist should review your medication list before treatment begins.

Do not start a new prescription medicine, over-the-counter medicine, herbal product, or supplement without checking whether it is appropriate with your oncology treatment.

What If You Miss a Dose?

If you miss a dose, follow the instructions provided by your prescribing healthcare professional or the medication guide supplied with your medicine. Do not take extra tablets to compensate for a missed dose unless your healthcare professional specifically instructs you to do so.

What If You Take Too Much Afatinib?

Taking more afatinib than prescribed can increase the risk of adverse reactions. Contact a healthcare professional or an appropriate emergency service promptly if you believe you have taken too much.

Storage Information

Store Xovoltib according to the product packaging and the instructions supplied by your pharmacist. Keep medicines away from children and pets. Do not use tablets that are damaged, altered, or past their expiry date.

Xovoltib 30 mg Frequently Asked Questions

What is Xovoltib 30 mg?

Xovoltib 30 mg is a tablet containing afatinib, a targeted anticancer medicine used for certain types of metastatic non-small cell lung cancer.

Is Xovoltib 30 mg chemotherapy?

Afatinib is a targeted cancer therapy rather than a traditional cytotoxic chemotherapy drug. It works by blocking specific receptor signaling pathways involved in cancer-cell growth.

What is Xovoltib 30 mg used for?

Afatinib is used for specific metastatic NSCLC settings, including tumors with certain non-resistant EGFR mutations and certain metastatic squamous NSCLC cases after platinum-based chemotherapy.

Is 30 mg the normal dose of afatinib?

Not for every patient. The U.S. prescribing information lists 40 mg once daily as the recommended dose for the indicated uses. A 30 mg dose may be appropriate in certain situations, such as severe renal impairment or dose modification.

Can I take Xovoltib with food?

Afatinib should be taken at least 1 hour before or 2 hours after a meal, according to the prescribing information.

Does Xovoltib cure lung cancer?

Afatinib is used to treat certain advanced or metastatic lung cancers. Treatment response varies between patients, and your oncologist determines the appropriate treatment strategy.

Who should prescribe Xovoltib?

Xovoltib is a prescription oncology medicine. Treatment should be prescribed and monitored by an appropriately qualified healthcare professional, particularly an oncology team familiar with targeted cancer therapy.

Related Information

For additional medicine information, visit our online medicine shop to browse available products and categories.

Medical Information Sources

For authoritative information about afatinib indications, safety warnings, and treatment considerations, consult:

• DailyMed – Afatinib Prescribing Information
• FDA – Afatinib Generic Drug Approval and Safety Information

Important Medical Disclaimer

This information is provided for educational purposes only and does not replace advice from a qualified healthcare professional. Xovoltib 30 mg (afatinib) is a prescription oncology medicine and should be used only under appropriate medical supervision. The information on this page does not establish a diagnosis, determine an individual’s treatment, or replace the prescribing information provided with the medicine.

Do not self-medicate with afatinib. The appropriate strength and treatment schedule depend on the cancer diagnosis, EGFR status, previous treatment, kidney function, other medical conditions, and tolerance of therapy. Always follow the instructions of your oncologist or prescribing healthcare professional.